Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes

doi:10.4254/wjh.v9.i12.603

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7238)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-6) series.

Item

Count

PDF

461

WORD

314

HTML

3145

Figures (1-6)

286

Tables (1-6)

259

Sum=4465

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1107

Download

1666

Sum=2773

Apr 28, 2017 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Apr 28, 2017; 9(12): 603-612
Published online Apr 28, 2017. doi: 10.4254/wjh.v9.i12.603

Full Size Figure Download Figure

Figure 6 Primary assisted patency rates of sub-maximally dilated (8 mm) vs maximally dilated (10 mm) transjugular intrahepatic portosystemic shunt. On Kaplan-Meier analysis, yearly patency rates through 6 years of follow-up after transjugular intrahepatic portosystemic shunt creation are demonstrated with 95%CI and number at risk.

Citation: Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017; 9(12): 603-612
URL: https://www.wjgnet.com/1948-5182/full/v9/i12/603.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i12.603